Background: Primary neurogenesis in Xenopus is a model for studying the control of neural cell fate decisions. The specification of primary neurons appears to be driven by transcription factors containing a basic region and a helix-loop-helix (HLH) motif: expression of Xenopus neurogenin-related-1 (X-ngnr-1) defines the three prospective domains of primary neurogenesis, and expression of XNeuroD coincides with neuronal differentiation. The transition between neuronal competence and stable commitment to a neuronal fate remains poorly characterised, however.
Background
Neural development in vertebrates starts during gastrulation with the demarkation of the neural plate, which is initially a field of undifferentiated, mitotically active cells. In anamniotic vertebrates such as Xenopus or the zebrafish, a first wave of cells withdraws from the mitotic cycle early during embryogenesis to generate a simple pattern of primary neurons that control early larval behaviour [1] . This early and precisely scheduled pattern makes primary neurogenesis in Xenopus an attractive model for the study of molecular and cellular mechanisms involved in neural cell fate decisions. Xenopus studies have shown that despite the gross anatomical and developmental differences between the vertebrate and Drosophila central nervous systems (CNSs), remarkably similar sets of genes and mechanisms are involved in neurogenesis in the two species [2, 3] .
The genetic control of neuroblast formation has been studied in considerable detail in Drosophila. Expression of a group of regulatory genes, the proneural genes, which encode transcription factors containing a basic region associated with a helix-loop-helix dimerisation motif (bHLH factors), is believed to render groups of cells competent to form neuronal progenitors. The selection of neuronal progenitors from each group of competent cells involves lateral inhibition, a cell-cell signalling mechanism by which cells committed to differentiate force neighbouring cells to remain uncommitted [2, 4] . In this process, the inhibitory signal Delta emitted by the nascent neural cells activates its transmembrane receptor Notch on adjacent cells [5] . Whereas the early action of proneural genes promotes the expression of Delta, expression of the proneural genes is down-regulated by activated Notch [6, 7] . It has been proposed that this feedback mechanism magnifies the small differences between adjacent cells in their levels of proneural gene expression; cells initially expressing higher levels of proneural activity than their neighbours become less sensitive to lateral inhibition and are consequently committed to a neural fate [8] . The nature of the events that stabilise neural fate and commit a cell irreversibly to neuronal differentiation have not yet been completely elucidated, however.
In Xenopus, the neuronal progenitors that give rise to the primary (larval) nervous system form in the neural plate in three longitudinal domains -medial, intermediate and lateral. The generation of these neurons is regulated by lateral inhibition mediated by Delta-Notch signalling in the same way as in Drosophila. Two recently identified bHLH transcription factors, Xenopus neurogenin-related-1 (X-Ngnr-1) and XNeuroD, are expressed in the progenitors of primary neurons [9, 10] . Expression of the X-ngnr-1 gene defines the three prospective domains of primary neurogenesis, and X-ngnr-1 has been proposed to act as a neuronal determination gene, perhaps analogous to the Drosophila proneural genes, whereas XNeuroD appears to act later, in the neuronal differentiation of committed cells. The temporal separation between X-ngnr-1 expression and the activation of XNeuroD suggested that intermediate factors in the cascade of transcriptional activation specifying the primary neuron progenitors were yet to be identified [10] .
We have cloned the Xenopus gene Xcoe2, which encodes a different transcription factor involved in the neurogenic cascade, by means of its homology to the rodent early Bcell factor/olfactory-1 (EBF/Olf-1) and Drosophila Collier (Col) transcription factors. The col gene was isolated as a regulator of Drosophila head patterning [11] , and EBF/Olf-1 was characterised independently both as a B-cell-specific factor (EBF [12] ) and as an olfactory-neuron-specific factor (Olf-1 [13] ). These proteins define a family of transcription factors with a type of DNA-binding domain associated with a HLH motif [11, 14] that had not been described previously. Two additional mouse genes of the same family have been identified recently: EBF-2/OE3/Mmot1 and EBF-3/OE2 [15] [16] [17] . Although slightly different results were reported concerning the respective timing and specificity of expression of each mouse EBF/OE gene, all three genes are transiently expressed in a subset of precursor cells in the embryonic CNS and the peripheral nervous system, concomitantly with the initiation of overt differentiation within the nervous system [15] [16] [17] . We have turned to the Xenopus embryo in order to investigate the early embryonic functions of the Col/Olf-1/EBF family of transcription factors. We show here that XCoe2, the homologue of EBF-2, is an essential component of primary neurogenesis in Xenopus, perhaps acting to connect X-Ngnr-1 and XNeuroD functions.
Results

Identification and embryonic expression of a Xenopus gene related to Drosophila collier and mouse EBF
To isolate Xenopus embryonic cDNAs related to the Drosophila collier and mouse EBF genes, we performed reverse transcriptase PCR using cDNAs from stage 25 embryos and degenerate oligonucleotide primers derived from conserved sequences flanking the DNA-binding domain of Col and EBF/Olf-1. (The same strategy, amplifying related sequences in the mouse, led to the isolation of EBF-2 and EBF-3 [15] .) DNA fragments of the expected size (560 bp) were amplified and cloned in bacteria. Analysis of 11 independent clones revealed coding sequences highly related to the Col/EBF DNA-binding domain although differing from each other at a few positions specific to each clone. Three of the eleven clones were identical, and the cDNA thus defined was used to probe a northern blot containing RNA from Xenopus embryos at different developmental stages. A single transcript, about 3 kb in length, was detected in neurula-stage embryos (data not shown). The same fragment was therefore used to screen a cDNA library from stage 17 Xenopus embryos [18] . Of 10 6 phages tested, six positive clones were isolated, differing only by the length of their 5′ ends.
Comparison between the largest cDNA obtained and the products of rapid amplification of cDNA ends (RACE) indicated that it was full length. Hybridisation of this cDNA clone to a developmental northern blot confirmed the zygotic expression of a 3 kb transcript, with expression starting at the neural plate stage and with a peak of transcript accumulation at the tailbud stage. A transcript of the same size was also detected in a subset of adult tissues: at high levels in the brain and low levels in the somatic muscles, testis, and possibly the spleen (Figure 1a and data not shown). Nucleotide sequencing revealed an open reading frame of 1767 nucleotides, predictive of a 589 amino-acid protein (Figure 1b ) highly related to Col and EBF/Olf-1. We named this gene Xcoe2 (Xenopus member of the Col/Olf-1/EBF family of transcription factors). Sequence alignment between XCoe2, Col, EBF, EBF-2 and EBF-3 (data not shown) confirmed the presence of two particularly well-conserved regions corresponding to the DNA-binding domain and the dimerisation domain, which includes an HLH motif (Figure 1b) [11] . XCoe2 appears, however, more closely related to EBF-2 than to either EBF or EBF-3, hence the suffix 2.
Comparison of the Col, EBF and XCoe2 amino-acid sequences with other protein sequences in the current databases revealed an extensive similarity with a predicted Caenorhabditis elegans open reading frame, which probably corresponds to the protein product of the unc-3 gene, originally identified in the genetic screen of S. Brenner [19] (T. Starrich, personal communication). A comparison of the predicted DNA-binding domains of Col, EBF and XCoe2 shows a small stretch of two or three amino-acid residues (boxed in Figure 1b ), specific to each protein, that might be considered a gene-specific 'signature'. The same signature was present in all 11 PCR products amplified from stage 25 Xenopus embryos, suggesting that during primary neurogenesis in Xenopus Xcoe2 is the most highly, if not the only, expressed coe gene.
Xcoe2 is an early marker of primary neurogenesis
To examine the role of Xcoe2 in Xenopus embryos, we first analysed its early embryonic expression by wholemount in situ hybridisation. Xcoe2 transcripts were first detected at the open neural-plate stage (stage 12), in a pattern anticipating that of the neuron-specific N-tubulin gene (Figure 2a ; see also Figure 3 ). N-tubulin expression was previously shown to mark the formation of three groups of primary neurons, arranged in a radially symmetrical pattern on either side of the dorsal midline, in the posterior neural plate. The medial (future ventral), intermediate and lateral (future dorsal) groups of neurons will later differentiate into motorneurons, interneurons and sensory neurons, respectively. Expression of Xcoe2 completely overlapped that of N-tubulin at stage 13, and this overlap included expression in the trigeminal placodes (Figure 2a) . Xcoe2 is therefore a new early marker of primary neurogenesis. At around stage 17, Xcoe2 began to be expressed in groups of anterior cells associated with the olfactory placodes, and in prospective anterior neural crest cells (Figure 2b ). When the neural tube closed, Xcoe2 expression in the spinal cord was restricted to the lateral zone, being absent from the mitotically active ventricular zone (Figure 2c ), as has already been observed for mouse EBF-2 [15] . From stage 28, this expression faded gradually, in an antero-posterior gradient, to become undetectable at stage 32 (compare Figure 2d and 2e ). These observations show that Xcoe2 is expressed only transiently in post-mitotic neurons.
Between stages 20 and 28, neural crest cells contributing to the mandibular, hyoid and third branchial arches express Xcoe2 (Figure 2d Tailbud  Tadpole  Kidney  Pancreas  Muscle  Spleen  Ovary  Testis  Brain 3.0 kbmay participate in the formation of the cartilaginous skeleton [20] . Other Xcoe2-expressing neural crest cells will contribute to the cranial ganglia. At stage 32, Xcoe2 expression remained strong in specific groups of cells in the mesencephalon and the rhombencephalon where neuronal differentiation was still proceeding, and in the olfactory placodes and cranial ganglia (Figure 2e ). Xcoe2 expression in early embryos was not restricted to neurectodermal cells, but also occurred transiently in cells located at the border between somites and lateral plates before these two mesodermal derivatives become separate ( Figure 2d and data not shown).
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Xcoe2 expression follows X-ngnr-1 and X-Dl1 but precedes N-tubulin and XNeuroD
On the basis of its early expression in the neural plate and its regulation by lateral inhibition, X-ngnr-1 has been proposed to be a proneuronal-like gene, encoding a protein that functions, at least in part, to activate X-Delta-1 (XDl1) and neural differentiation genes such as N-tubulin and XNeuroD [10] . In order to investigate further the possible function of Xcoe2 during primary neurogenesis, we compared in detail its temporal pattern of expression relative to the expression of these other genes. The earliest expression of Xcoe2 occurs at stage 12, after X-Dl1 and Xngnr-1 expression has become restricted to the prospective neuronal progenitors by lateral inhibition (Figure 3a ) [10, 21] . Xcoe2 expression anticipates the pattern of all primary neurons as marked by N-tubulin expression at stage 12.5. It also anticipates the expression of XNeuroD, which is not detected prior to stage 13.5, and then only in a subset of cells expressing Xcoe2 and X-ngnr-1 ([9,10] and data not shown). The sequential order of transcription of the known HLH transcription factors involved in Xenopus primary neurogenesis therefore starts with X-ngnr-1, followed by Xcoe2 and then, significantly later, XNeuroD. In order to determine whether Xcoe2 expression was controlled by X-ngnr-1, we injected X-ngnr-1 mRNA into one blastomere of embryos at the two-cell stage and looked at Xcoe2 mRNA at developmental stage 14 by in situ hybridisation. A lacZ mRNA marker was co-injected and the distribution of β galactosidase activity was used to assess the distribution of the injected mRNAs. All 26 injected embryos examined showed ectopic Xcoe2 mRNA on the injected side, in both the neural plate and the epidermis, indicating that X-ngnr-1 ectopically activates Xcoe2 transcription (Figure 3b) . Together, the temporal and spatial expression of Xcoe2 and its activation by Xngnr-1 suggested that Xcoe2 acts at an early stage in the neurogenic cascade, upstream of neuronal differentiation genes such as XNeuroD.
Decreasing XCoe2 activity prevents neuronal specification
To determine whether Xcoe2 is required for the specification of primary neurons, we attempted to decrease XCoe2 activity in embryos by overexpressing a dominant-negative mutant form of the protein. The design of this mutant protein, XCoe2 ∆DBD , was based on the functional dissection of the EBF/Olf-1 protein in vitro [12, 14] and on the high structural conservation of the dimerisation region and DNA-binding domain in all members of the Coe family ( Figure 1b) . XCoe2 ∆DBD has a truncation that removes the DNA-binding domain but leaves the dimerisation domain intact (Figure 4a ). We hypothesised that overexpressing this truncated protein would titrate the native XCoe2 and prevent its normal function via the formation of XCoe2-XCoe2 ∆DBD heterodimers that are not able to bind DNA properly [12] . Xcoe2 ∆DBD and lacZ mRNAs were injected into embryos at the four-cell stage. As a result, cells expressing N-tubulin or X-NeuroD were absent or drastically reduced in number in the regions of the embryo expressing injected mRNA, as defined by staining for β-galactosidase activity (compare Figure 4b and c,d; 74% (n = 65) and 72% (n = 36) of embryos have reduced numbers of cells expressing N-tubulin and XNeuroD, respectively). This effect was completely reversed when mRNA encoding full-length XCoe2 was co-injected with Xcoe2 ∆DBD mRNA (data not shown), indicating that XCoe2 ∆DBD specifically antagonises XCoe2 activity. In order to determine at which stage XCoe2 ∆DBD blocked the neuronal determination process, we examined the patterns of expression of X-ngnr-1 at stages 11.5 and 14, and activation of endogenous Xcoe2 at stage 12, using the 5′-specific probe defined in Figure 4a . Normal patterns of X-ngnr-1 and Xcoe2 expression were observed at stage 11.5-12, (Figure 4e ,g; 100% of embryos, n = 26, expressed X-ngnr-1 in a normal pattern, 84%, n = 49, expressed Xcoe2 in a normal pattern), indicating that XCoe2 ∆DBD blocks the neuronal specification process only after the onset of endogenous Xcoe2 expression. We noted a significant reduction of X-ngnr-1 expression as early as stage 12.5 on the injected side in 65% of embryos (n = 40), however, suggesting that XCoe2 activity is required to maintain X-ngnr-1 transcription in selected progenitor cells (Figure 4f ). When embryos injected with Xcoe2 ∆DBD mRNA reached the tadpole stage, most did not show a proper escape response, being unable to contract on one side, a phenotype suggestive of unilateral innervation defects. Given also the sequence of expression X-ngnr-1, Xcoe2 and XNeuroD, the block of neuronal differentiation resulting from overexpression of XCoe2 ∆DBD suggests that XCoe2 is essential for the specification of primary neurons in the Xenopus embryo, acting downstream of X-ngnr-1 and upstream of XNeuroD. It may act partly through a positive-feedback regulation of X-ngnr-1 expression in selected progenitor cells.
Ectopic Xcoe2 induces ectopic neurogenesis in only scattered cells of both the neural plate and the epidermis
The results described above suggest that XCoe2 is necessary for primary neurogenesis, so we next asked whether XCoe2 is sufficient to induce ectopic neurogenesis. Xcoe2 was overexpressed in Xenopus embryos by injecting Xcoe2 mRNA (together with lacZ mRNA) at the two-cell or fourcell stage. The pattern of neurogenesis in Xcoe2-injected embryos was examined at various intervals by in situ hybridisation with probes for XNeuroD and N-tubulin. Overexpression of Xcoe2 mRNA caused ectopic neurogenesis both within the neural plate and in regions of presumptive epidermis. At stage 15-16, scattered cells on the injected side appeared to express XNeuroD (Figure 5a ,c; 65% of embryos, n = 48) or N-tubulin (71% of embryos, n = 70, data not shown) in the neural plate and epidermis, whereas the three stripes of primary neurogenesis were normal on the uninjected side ( Figure 5a ). Because Xcoe2 ∆DBD injection experiments indicated a feedback regulation of X-ngnr-1 transcription by Xcoe2 after stage 12, we examined X-ngnr-1 expression in Xcoe2-injected embryos. Figure 5b shows that X-ngnr-1 is ectopically activated in response to Xcoe2 RNA overexpression and, as observed with XNeuroD, in a scattered cell pattern (86% of embryos, n = 36). At the tailbud stage (stage 25), cells expressing Ntubulin or XNeuroD ectopically were still observed within the epidermis (Figure 5c and data not shown). We verified that some of these cells differentiated into neurons by staining stage 30 embryos with antibodies directed against the neural cell adhesion molecule (N-CAM), a general marker of neural tissue that remains expressed during terminal neuronal differentiation (Figure 5d ,e). Differentiated neurons with axonal projections were observed in the epidermis on the injected side of the embryo, confirming that Xcoe2 overexpression is sufficient to promote neuronal fate in ectoderm that is normally non-neurogenic.
The pattern of Xcoe2-induced ectopic neurons results from the ectopic activation of X-Dl1 and lateral inhibition
Whereas in embryos injected with either X-ngnr-1 mRNA or X-NeuroD nearly all cells of the neural plate on the injected side expressed N-tubulin [10] , in embryos injected with Xcoe2 mRNA, cells expressing X-ngnr-1, N-tubulin or XNeuroD always appeared scattered ( Figure 5 ). This saltand-pepper pattern suggested that Xcoe2 neural function is regulated by lateral inhibition. As X-Dl1 is not expressed in the epidermis (Figure 3a ) [21] , we first tested whether Xcoe2 activates X-Dl1 transcription. In situ hybridisation of embryos injected with Xcoe2 mRNA showed that X-Dl1 was ectopically expressed in the epidermis by stage 12.5 in 65% of embryos (n = 109). In contrast to X-ngnr-1, XNeuroD or N-tubulin ( Figure 5 ), X-Dl1 appeared to be ectopically activated more or less uniformly in all cells in the region of injection (Figure 6a ). The ectopic X-Dl1 transcripts became redistributed into patches of clustered cells during the developmental period between stages 14 and 17 ( Figure 6b ).
Although we have not investigated this patching in more detail, we noted that, during the same period, cells expressing ectopic N-tubulin or X-NeuroD (Figure 5c and data not shown) also redistributed into small patches (Figure 6c ). Furthermore, in situ hybridisation with a combination of X-Dl1 and N-tubulin probes showed that the N-tubulin-positive cells were mostly located within the patches of X-Dl1-expressing cells, but only at the border with cells that did not express X-Dl1 (Figure 6c ). This was consistent with the observation that production of primary neurons is inhibited when all cells are artificially caused to express X-Dl1 [21] . The scattered distribution of Xcoe2-induced neurons indicates that Xcoe2 neural function is regulated by lateral inhibition. This regulation occurs in the epidermis as a result of ectopic activation of X-Dl1 expression by injected Xcoe2. The sensitivity of Xcoe2 neural function to lateral inhibition was confirmed by co-injecting into embryos Xcoe2 mRNA and an mRNA encoding a dominant-negative form of X-Dl1 (X-Dl1 stu , renamed X-Dl1 dn ) [21, 22] . Co-expression of Xcoe2 and XDl1 stu resulted in a dramatic increase in both the penetrance of ectopic neurogenesis (93% of embryos; n = 46) and the density of supernumerary neurons induced by Xcoe2 in both the neural plate and the epidermis (compare Figure 6d and e), whereas injections of X-Dl1 dn alone lead to supernumerary neuron formation only in the neural plate (Figure 6f ) [21] . We conclude from these experiments that Xcoe2 positively regulates the transcription of XDl1, and that its ability to drive neuronal differentiation is highly sensitive to lateral inhibition ( Figure 7 ).
Discussion
In this report, we have investigated the role of XCoe2, an HLH transcription factor of a new type, in the specification of primary neurons in the Xenopus embryo. Results from both gain-of-function and loss-of-function experiments lead us to propose that Xcoe2 is required for the stable commitment of selected progenitor cells to a neural fate. XCoe2 acts downstream of X-ngnr-1 to maintain both Delta-Notch signalling and high levels of Xngnr-1 expression in selected progenitor cells and is required for the activation of neural differentiation genes such as XNeuroD.
XCoe2, an HLH factor in the transcriptional activation cascade controlling primary neurogenesis
Xcoe2 is transiently expressed in differentiating primary neurons and is both necessary for primary neurogenesis and able to convert epidermal cells into neurons. Temporally, Xcoe2 is activated after X-ngnr-1 and before XNeuroD in spatially overlapping patterns within the three prospective areas of primary neurogenesis. Gain-of-function experiments show that X-ngnr-1 is able to activate the transcription of Xcoe2, and Xcoe2 can in turn activate X-Dl1 and XNeuroD, as well as X-ngnr-1, in a positive-feedback mechanism. Conversely, in the presence of a dominantnegative mutant form of XCoe2, the selected progenitor cells which express Xcoe2 lose X-ngnr-1 expression and do not commit to a neural fate. Together, these results suggest that Xcoe2 plays a pivotal role during primary neurogenesis in enforcing X-ngnr-1 proneural function and in promoting neuronal differentiation of committed cells by activating the expression of genes such as XNeuroD either directly or indirectly (perhaps through the maintenance of X-ngnr-1 expression). Activation of Xcoe2 occurs at stage 12, whereas XNeuroD transcripts accumulate from stage 13.5 ([9,10,23] and this report). The time window between activation of Xcoe2 and XNeuroD, during which the vast majority of primary neuron progenitors are in the last G2 phase preceding their exit from the mitotic cycle [1] , might allow specified neuronal progenitors to interact with spatio-temporally regulated signals in their microenvironment, and to adopt the fate they will express post-mitotically, in a cell-autonomous manner.
From selection to differentiation of primary neural progenitors
Expression of the proneural achaete-scute complex (AS-C) genes in the Drosophila neurectoderm defines domains in which all cells are competent to become neuroblasts, as revealed in neurogenic mutants [24] . Only a selected number of these cells do, however, become irreversibly committed to a neural fate. Whereas the transcriptional feedback loop involving Notch-Delta signalling may not provide the main mechanism of neuroblast selection, it is required for the refinement/maintenance of this selection process so as to ensure the segregation of the correct number of neuroblasts at the right time and position [25] . This, together with experiments in Xenopus embryos and retinae and the embryonic chick retina, indicates that Delta-Notch signalling regulates the proportion of progenitors that become committed to the neuronal fate [22, [25] [26] [27] .
Whereas expression of the proneural-type gene X-ngnr-1 makes a cell competent to become a neuronal progenitor, the factors that stabilise the competent state and control
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Figure 6
Xcoe2 ectopically activates, and is regulated by, lateral inhibition. One cell of a Xenopus embryo at the two-cell or four-cell stage was injected with (a-d) XCoe2 (400 pg) and lacZ (50 pg) mRNAs; a combination of (e) XCoe2 ( Probe:
Inj:
the transition between competence and irreversible commitment to become a primary neuron remained to be defined [10] . That XCoe2 is such a factor is supported by several lines of evidence. First, Xcoe2 is required for the maintenance of X-ngnr-1 expression in selected progenitor cells during their transition from selection to differentiation. Second, Xcoe2 is able to activate X-Dl1 expression. Third, its ability to ectopically activate X-ngnr-1 and XNeuroD in only scattered cells indicates that its neuralpromoting function is highly sensitive to lateral inhibition. The difference between the patterns of X-Dl1 and X-ngnr-1 expression also indicates that X-Dl1 activation is a primary response to XCoe2 overexpression rather than a secondary response mediated by X-Ngnr-1. This genetic interaction between Xcoe2 and Delta-Notch signalling was confirmed by the increased density of ectopic neurons induced by overexpressed Xcoe2 in the presence of a dominant-negative form of X-Dl1, X-Dl1 dn , which renders cells 'deaf' to lateral inhibition [21, 22] .
To date, XCoe2 is the only transcription factor whose ability to induce ectopic neurons in the epidermis is highly sensitive to lateral inhibition. Overexpression of the bHLH protein XASH-3 (Xenopus AS-C homologue-3) also results in a scattered pattern of ectopic neurons [26] , but in contrast to XCoe2, XASH-3 promotes neurogenesis only in the neural plate [28, 29] . Because X-ngnr-1 (or Xcoe2) and XASH-3 are expressed in largely non-overlapping groups of cells in the neural plate ( [10, [28] [29] [30] and this report), it is possible that different pathways of neuronal specification operate during Xenopus early embryogenesis, involving different genes with similar proneural functions, as is the case in Drosophila for AS-C and atonal. X-Myt, a zinc-finger transcriptional activator, has been proposed to cooperate with the proneural bHLH proteins X-Ngnr-1 and XASH-3 to promote their proneural activity in selected progenitor cells, although probably not by directly interfering with the lateral inhibitory circuit [23] . Whether X-Myt plays a role in the positive-feedback regulation of X-ngnr-1 remains to be examined.
206 Current Biology, Vol 8 No 4
Figure 7
Model for the transcriptional interactions controlling the specification of primary neurons in Xenopus. X-ngnr-1, Xcoe2 and XNeuroD are sequentially activated in primary neuron progenitors. Expression of X-ngnr-1 renders cells competent to adopt a neural fate [10] . Expression of X-Ngnr-1 above a certain threshold leads to activation of Xcoe2 in selected progenitor cells. XCoe2 activity is required for stable commitment of these cells to a neural fate via the maintenance of Delta-Notch signalling and a positivefeedback regulation of X-ngnr-1 expression. XCoe2 is also required for the expression of differentiation genes such as XNeuroD. Whether this activation is direct or is through the maintenance of high levels of X-ngnr-1 expression, or both, remains to be determined. The time window between activation of Xcoe2 and XNeuroD, at stages 12 and 13.5, respectively, during which the majority of primary neurons are in the last G2 phase preceding their exit from the mitotic cycle [1] , might allow neuron progenitors to respond to spatially and temporally regulated environmental cues. 
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Current Biology HLH motifs, which mediate homodimerisation and/or heterodimerisation, have so far been found in two types of transcription factor: bHLH proteins, all of which bind to similar DNA sequences collectively designated E boxes; and proteins lacking the basic region. This second group of proteins has been shown to antagonise the function of bHLH proteins by forming heterodimers that are unable to bind DNA. Although there is no evidence so far for heterodimer formation between Coe proteins and other types of HLH proteins, it has been established previously that EBF-1 binds to DNA as a dimer [12, 14, 32, 33] . Furthermore, all three mouse Coe proteins are able to dimerise with themselves and with the other members of the family [17] . Recently, EBF-1 and the bHLH protein E47 have been shown to collaborate to induce expression of the early B-lymphocyte-specific gene λ5. In this case, the synergy between the two transcription factors relies upon the multiplicity of their binding sites in the λ5 promoter rather than synergistic protein-protein interactions [33] . Complex families of bHLH transcription factors related to the Drosophila proneural proteins AS-C or Atonal (the NeuroD, Neurogenin or MATH families) have been identified recently in the mouse and chicken [34] [35] [36] [37] . Thus, there are already a large number of putative neuronal determination or differentiation factors with which Coe proteins potentially interact, in both the central and peripheral nervous systems. Like the EBFs [15, 17] , the several neurogenin genes in the mouse also form a family with partly overlapping expression patterns in the spinal cord, the brain, neural crest cells or the olfactory placodes, which might activate NeuroD in different sublineages [34, 35] . It remains a challenging question whether interaction between different Coe proteins and bHLH proteins in the nervous system is limited to directional cascades of transcriptional activation or involves synergistic interactions on specific promoters to activate subsets of genes in a combinatorial fashion.
Conclusions
This analysis reveals an important role for XCoe2, an HLH transcription factor (of the Coe family), in the specification of primary neurons in Xenopus. Both the temporal pattern of Xcoe2 expression and the requirement for Xcoe2 in order for selected progenitor cells to become committed to a neural fate define a new step in primary neurogenesis: a switch between neural competence (conferred by the proneural-like gene X-ngnr-1) and neuronal differentiation ( Figure 7) . Like Xcoe2 and zfcoe2 in the zebrafish (L.B-C., unpublished observations), EBF/OE genes in the mouse are transiently expressed in differentiating neurons in the CNS, in the zone extending from the midbrain to the spinal cord and in specific regions of the anterior brain [15] . These data are consistent with a conserved role for Coe transcription factors in the control of neuronal differentiation in the vertebrate CNS.
Materials and methods
Isolation of cDNA
Random-primed cDNA was prepared from embryonic stage 25 Xenopus RNA. Degenerate oligonucleotide primers were designed, based on conserved amino-acid sequences within the DNA-binding domain of the Drosophila Col and mouse EBF proteins [15] : 3′ degenerate primer 5′TT(A/G)TT(A/G)TGNAC(A/G)AACAT(A/G)TT(A/G)TC3′ corresponds to the peptide sequence DNMFVHNN (in single-letter amino-acid code) and 5′ degenerate primer 5′GCNCA(C/T)-TT(T/C)GA(A/G)AA(A/G)CA(A/G)CC3′ corresponds to the peptide sequence AHFEKQP. These primers were used for PCR amplification under conditions described by the manufacturer (Cetus). Amplification was for 30 cycles at 94°C for 1 min, 50°C for 2 min and 72°C for 3 min. PCR products of the appropriate size (560 bp) were purified by gel electrophoresis, subcloned and sequenced. The fragment corresponding to the most abundant class of PCR products was used as a probe to screen a stage 17 embryo cDNA library in λgt10. Six cDNAs that encode Col/EBF-related proteins were identified in a screen of 10 6 colonies. The largest cDNA (2.2 kb), which contains a complete open reading frame, was subcloned in pBSKS, and its nucleotide sequence was determined using the Pharmacia sequencing kit. The GenBank Accession number for the Xcoe2 sequence is AF041138.
In situ hybridisation, antibody staining and histology
The 2.2 kb Xcoe2 cDNA, cloned in pBSKS, was linearised with XbaI and transcribed with T3 RNA polymerase to generate a digoxigeninlabelled antisense RNA probe. The 5′ Xcoe2 probe was generated using the 5′ EcoRI-Aflll Xcoe2 cDNA fragment (686 bp) cloned in pBSKS. The XNeuroD, X-Dl1 and N-tubulin probes were prepared as described [9, 26, 38] . Embryos were staged according to Nieuwkoop and Faber [39] . Whole-mount in situ hybridisation was performed using the procedure of Harland [40] , with the following modifications: pre-blocking of the alkaline-phosphatase-conjugated digoxigenin antibody [41] ; incubation of embryos for 1 h at room temperature in blocking solution (Boehringer Mannheim); and staining with BM purple (Boehringer Mannheim). Double-labelling whole-mount in situ hybridisation was performed as described [22] , using digoxigenin-labelled XDl1 and fluorescein-labelled N-tubulin RNA probes. Embryos were stained with anti-N-CAM antibody (1/20 dilution) as described [42] , following in situ hybridisation or immunohistochemistry; some embryos were cleared in 2:1 benzyl benzoat : benzyl alcohol. Sections (10 µm) were made from stained paraffin-embedded embryos.
RNA synthesis and injection
The entire Xcoe2 cDNA was cloned into the EcoRI site of the RN3 vector [43] . To synthesise RNAs coding for a truncated XCoe2 protein lacking part of the DNA-binding domain (XCoe2 ∆DBD ), the PstI-XhoI 3′ fragment of Xcoe2 (corresponding to amino acids 303-589) was cloned in-frame into the StuI site of the plasmid pCS2+MT [28] . Capped Xcoe2 and Xcoe2 ∆DBD mRNAs were transcribed using the T3 and SP6 Cap-Scribe, respectively (Boehringer Mannheim). X-ngnr-1 [10] , X-Dl1 dn and NLSlacZ [21] RNAs were prepared as originally described, and were injected at a concentration of 2-100 pg/nl, in a volume of 5 nl, into a single blastomere of two-to eight-cell embryos. In most experiments, lacZ mRNA was co-injected as a marker; injection of lacZ mRNA alone was used as a control. Histochemical staining for β galactosidase was used to visualise the distribution of injected mRNAs. Embryos were collected at either the neural plate stage (stage 12.5-15) or tailbud stage (stage [25] [26] [27] [28] and subjected to in situ hybridisation as described above.
